Physician profile
Priya Patel
NPI 1568025443
$1,849.99
in general payments reported to CMS, 2019-2025
22 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $34.04 · 2021: $691 · 2022: $549 · 2023: $53.46 · 2024: $66.37 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $360.34 | 2025 | Idosetr, Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Genzyme Corporation | $251.74 | 2020-2021 | |
| Abbvie INC. | $225.87 | 2021-2022 | |
| Glaxosmithkline, LLC. | $186.48 | 2021-2025 | Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $172.26 | 2020-2025 | Farxiga |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $97.47 | 2021 | |
| Allergan, INC. | $90.86 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $39.75 | 2022-2023 | Rexulti |
| Merck Sharp & Dohme LLC | $32.77 | 2021-2022 | |
| Exact Sciences Corporation | $31.60 | 2023-2025 | Cologuard Collection Kit |
| Harrow Eye, LLC | $29.32 | 2025 | Triesence |
| Lilly USA, LLC | $24.79 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.61 | 2022 | |
| Organon LLC | $23.90 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $22.42 | 2024 | Rybelsus, Ozempic |
| Pfizer INC. | $22.16 | 2024 | |
| Dompe US, INC. | $21.79 | 2024 | Oxervate |
| Lundbeck LLC | $19.43 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.88 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.91 | 2022 | |
| Amarin Pharma, INC. | $14.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.